Cerebral venous and sinus thrombosis diagnosis: preliminary study of clinical picture and D-dimer concentration correlation.

cerebral venous and sinus thrombosis d-dimer number of venous sinuses involvement symptoms duration

Journal

Neurologia i neurochirurgia polska
ISSN: 0028-3843
Titre abrégé: Neurol Neurochir Pol
Pays: Poland
ID NLM: 0101265

Informations de publication

Date de publication:
2020
Historique:
received: 17 09 2019
accepted: 16 11 2019
revised: 15 11 2019
pubmed: 23 1 2020
medline: 5 3 2020
entrez: 23 1 2020
Statut: ppublish

Résumé

We investigated whether D-dimer (DD) concentration is elevated in cerebral venous and sinus thrombosis (CVST), as has been reported in the literature. CVST is a disease with variable clinical presentations and a challenging diagnosis. We looked into whether D-dimer concentration might be an indicator of CVST, and the need for neuroimaging tests correlated with clinical factors. We included all consecutive patients (mean age 41.6 years) with CVST treated in our neurology department from 2014 to 2018 whose DD levels had been measured. DD concentrations were categorised as normal (≤ 0.5 μg/ml) or elevated ( > 0.5 μg/ml). Appropriate imaging confirmed the diagnosis of CVST. The results were compared to those of a control group consisting of 22 age- and sex-matched patients (mean age 40 years) with a diagnosis of primary headache (tension type or migraine) hospitalised to exclude secondary causes. In 20 patients in the CVST study group, median level of DD was 1.0 + 0.57 μg/ml (range 0.19-2.45 μg/ml), compared to the control group's mean DD level of 0.50 + 0.45 μg/ml (range 0.15-1.73 μg/ml), with p < 0.005. Higher DD levels were associated with complications of the disease and fatal course (p < 0.005). One female and one male patient died because of CVST with DD levels of (respectively) 2.45 and 1.80 μg/ml - the two highest concentrations in our study group. DD concentration, especially in headache patients, may be a factor to predict CVST and an indicator for further diagnostic procedures with venography. But in clinical practice, low levels of DD cannot be taken to exclude CVST.

Identifiants

pubmed: 31965561
pii: VM/OJS/J/65764
doi: 10.5603/PJNNS.a2020.0006
doi:

Substances chimiques

Fibrin Fibrinogen Degradation Products 0
fibrin fragment D 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-72

Auteurs

Izabela Domitrz (I)

Department of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, Warsaw, Poland, Cegłowska 80, 01-809 Warsaw, Poland.

Artur Sadowski (A)

Department of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, Warsaw, Poland, Cegłowska 80, 01-809 Warsaw, Poland. asadowski255@gmail.com.

Wojciech Domitrz (W)

Faculty of Mathematics and Information Science, Warsaw University of Technology, Koszykowa 72 st., 00-662 Warsaw, Poland.

Jan Kochanowski (J)

Department of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, Warsaw, Poland, Cegłowska 80, 01-809 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH